In particular, increased or constitutively activated expression of the epidermal growth factor receptor (EGFR) accounts for a significant proportion of PCa patients and is strongly associated with a high relapse rate, poor prognosis and progression to castration-resistant status 7-10. The gene discussed is EGFR; the disease is posterior cortical atrophy.